Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Tumor Suppressor Protein p53"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-7 z 7
    Tytuł:
    [Targeting microRNA-125b inhibited the metastasis of Alisertib resistance cells through mediating p53 pathway].
    Autorzy:
    Yang FL; Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Jiangsu Province Key Laboratory of Immunity and Metabolism, National Experimental Teaching Demonstration Center of Basic Medicine, Xuzhou Medical University, Xuzhou 221000, China.
    Chen X; Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Jiangsu Province Key Laboratory of Immunity and Metabolism, National Experimental Teaching Demonstration Center of Basic Medicine, Xuzhou Medical University, Jiangsu International Joint Laboratory for Immunology and Metabolism, Xuzhou 221000, China.
    Zheng F; Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Jiangsu Province Key Laboratory of Immunity and Metabolism, National Experimental Teaching Demonstration Center of Basic Medicine, Xuzhou Medical University, Xuzhou 221000, China.
    Liu XX; Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Jiangsu Province Key Laboratory of Immunity and Metabolism, National Experimental Teaching Demonstration Center of Basic Medicine, Xuzhou Medical University, Jiangsu International Joint Laboratory for Immunology and Metabolism, Xuzhou 221000, China.
    Sun N; Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Jiangsu Province Key Laboratory of Immunity and Metabolism, National Experimental Teaching Demonstration Center of Basic Medicine, Xuzhou Medical University, Jiangsu International Joint Laboratory for Immunology and Metabolism, Xuzhou 221000, China.
    Li RQ; Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Jiangsu Province Key Laboratory of Immunity and Metabolism, National Experimental Teaching Demonstration Center of Basic Medicine, Xuzhou Medical University, Jiangsu International Joint Laboratory for Immunology and Metabolism, Xuzhou 221000, China.
    Jiang Z; Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Jiangsu Province Key Laboratory of Immunity and Metabolism, National Experimental Teaching Demonstration Center of Basic Medicine, Xuzhou Medical University, Xuzhou 221000, China.
    Han J; Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Jiangsu Province Key Laboratory of Immunity and Metabolism, National Experimental Teaching Demonstration Center of Basic Medicine, Xuzhou Medical University, Jiangsu International Joint Laboratory for Immunology and Metabolism, Xuzhou 221000, China.
    Yang J; Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Jiangsu Province Key Laboratory of Immunity and Metabolism, National Experimental Teaching Demonstration Center of Basic Medicine, Xuzhou Medical University, Jiangsu International Joint Laboratory for Immunology and Metabolism, Xuzhou 221000, China.
    Pokaż więcej
    Źródło:
    Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Jun 23; Vol. 45 (6), pp. 499-507.
    Typ publikacji:
    English Abstract; Journal Article
    MeSH Terms:
    MicroRNAs*/genetics
    Tumor Suppressor Protein p53*/genetics
    Drug Resistance, Neoplasm*
    Animals ; Female ; Mice ; Azepines ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation ; Gene Expression Regulation, Neoplastic ; RNA, Messenger ; Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    [The influence of TP53 mutation on the therapeutic effect of EGFR tyrosine kinase inhibitor and prognosis of EGFR mutant non-small cell lung cancer patients].
    Autorzy:
    Xiayimaierdan Y; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100021, China.
    Song P
    Gao SG
    Pokaż więcej
    Źródło:
    Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2020 Jan 23; Vol. 42 (1), pp. 74-77.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Carcinoma, Non-Small-Cell Lung*/drug therapy
    Carcinoma, Non-Small-Cell Lung*/genetics
    Lung Neoplasms*/drug therapy
    Lung Neoplasms*/genetics
    Protein Kinase Inhibitors*/therapeutic use
    Tumor Suppressor Protein p53*/genetics
    Decision Making ; ErbB Receptors/genetics ; Humans ; Mutation ; Patient Care Planning ; Prognosis ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    [The analysis of genetic and clinicopathologic characteristics in patients with follicular thyroid neoplasm].
    Autorzy:
    Zhang J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
    Li Y
    Lyu N
    Ying JM
    Pokaż więcej
    Źródło:
    Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2019 Aug 23; Vol. 41 (8), pp. 594-598.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Adenocarcinoma, Follicular/*genetics
    Adenocarcinoma, Follicular/*pathology
    Thyroid Neoplasms/*genetics
    Thyroid Neoplasms/*pathology
    Humans ; Lymphatic Metastasis/genetics ; Mutation ; Retrospective Studies ; Tumor Suppressor Protein p53/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    [Prognostic value of combined expression of Aurora A, p53 and p21 WAF1 in patients after curative resection of non-small cell lung cancer].
    Autorzy:
    Li X; Departments of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Oncology Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin 300060, China.
    Liu N
    Ren P
    Cao Q
    Wang P
    Zhao L
    Lu B
    Wang P; Email: .
    Pokaż więcej
    Źródło:
    Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2015 Jul; Vol. 37 (7), pp. 512-6.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Aurora Kinase A/*metabolism
    Carcinoma, Non-Small-Cell Lung/*metabolism
    Cyclin-Dependent Kinase Inhibitor p21/*metabolism
    Ki-67 Antigen/*metabolism
    Lung Neoplasms/*metabolism
    Tumor Suppressor Protein p53/*metabolism
    Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/surgery ; Humans ; Immunohistochemistry ; Lung Neoplasms/mortality ; Lung Neoplasms/surgery ; Prognosis ; Survival Analysis ; Survival Rate
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-7 z 7

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies